EUVIMEDEUVIMED entdecken
Crossref

Assessment of Oral Manifestation and Inflammatory Markers (IL-17) in End Stage Chronic Kidney Disease Patients: A Cross Sectional Study

Aya M. Redha, Hassan A. Barazanji

Erbil Dental Journal · 30.06.2026 · 9 (1) · 145-150

DOI: 10.15218/edj.2026.17 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Erbil Dental Journal, online erschienen am 30.06.2026. Verfasst von Aya M. Redha und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Chronic kidney disease (CKD) is a progressive condition characterized by irreversible deterioration of kidney function, resulting in systemic complications that may adversely affect oral health. Patients undergoing hemodialysis frequently present with various oral manifestations due to metabolic disturbances, medication use, and altered immune responses. Interleukin-17 (IL-17) is an inflammatory cytokine involved in host defense against Candida albicans and may play a role in the oral health status of CKD patients. This study aimed to evaluate oral manifestations and serum IL-17 levels in patients with end stage chronic kidney disease undergoing hemodialysis.

Methods

A cross-sectional study was conducted on 60 participants, including 30 patients with CKD undergoing hemodialysis for more than six months and 30 healthy controls matched for sex. Clinical examinations included assessment of oral dryness, salivary flow rate (sialometry), periodontal status, halitosis, coated tongue, pale oral mucosa, and lip fissures. Serum IL-17 levels were measured using laboratory analysis. Data were analyzed using independent samples t-test and Chi-square test, with statistical significance set at p < 0.05.

Results

Dry mouth, pale oral mucosa, and lip fissures were significantly more prevalent among CKD patients than controls (p < 0.05). Salivary flow rate was significantly reduced, while periodontal disease severity was significantly increased in the CKD group. Although serum IL 17 levels were higher in CKD patients than in healthy controls, the difference was not statistically significant (p = 0.182).

Conclusion

Patients with chronic kidney disease undergoing hemodialysis exhibit a higher prevalence of oral manifestations and periodontal disease compared with healthy individuals. Regular oral healthcare and preventive dental measures are essential for improving oral health outcomes in this population. Keywords: Chronic kidney disease, Hemodialysis, Oral manifestations, Interleukin-17, Periodontal disease, Xerostomia

Zitieren

APA

Redha, A. M., & Barazanji, H. A. (2026). Assessment of Oral Manifestation and Inflammatory Markers (IL-17) in End Stage Chronic Kidney Disease Patients: A Cross Sectional Study. Erbil Dental Journal, 9(1), 145-150. https://doi.org/10.15218/edj.2026.17

Vancouver

Redha AM, Barazanji HA. Assessment of Oral Manifestation and Inflammatory Markers (IL-17) in End Stage Chronic Kidney Disease Patients: A Cross Sectional Study. Erbil Dental Journal. 2026;9(1):145-150. doi:10.15218/edj.2026.17

BibTeX
@article{Redha2026,
  author = {Redha, Aya M. and Barazanji, Hassan A.},
  title = {Assessment of Oral Manifestation and Inflammatory Markers (IL-17) in End Stage Chronic Kidney Disease Patients: A Cross Sectional Study},
  journal = {Erbil Dental Journal},
  year = {2026},
  volume = {9},
  number = {1},
  pages = {145--150},
  doi = {10.15218/edj.2026.17}
}
Kostenlos starten →